Details

Autor(en) / Beteiligte

• Silverberg, Michael J.
• Lau, Bryan
• Justice, Amy C.
• Engels, Eric
• Gill, M. John
• Goedert, James J.
• Kirk, Gregory D.
• D'Souza, Gypsyamber
• Bosch, Ronald J.
• Brooks, John T.
• Napravnik, Sonia
• Hessol, Nancy A.
• Jacobson, Lisa P.
• Kitahata, Mari M.
• Klein, Marina B.
• Moore, Richard D.
• Rodriguez, Benigno
• Rourke, Sean B.
• Saag, Michael S.
• Sterling, Timothy R.
• Gebo, Kelly A.
• Press, Natasha
• Martin, Jeffrey N.
• Dubrow, Robert

Titel

Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America

Ist Teil von

• Clinical infectious diseases, 2012-04, Vol.54 (7), p.1026-1034

Ort / Verlag

Oxford: Oxford University Press

Erscheinungsjahr

2012

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• Background. Anal cancer is one of the most common cancers affecting individuals infected with human immunodeficiency virus (HIV), although few have evaluated rates separately for men who have sex with men (MSM), other men, and women. There are also conflicting data regarding calendar trends. Methods. In a study involving 13 cohorts from North America with follow-up between 1996 and 2007, we compared anal cancer incidence rates among 34 189 HIV-infected (55% MSM, 19% other men, 26% women) and 114 260 HIV-uninfected individuals (90% men). Results. Among men, the unadjusted anal cancer incidence rates per 100 000 person-years were 131 for HIV-infected MSM, 46 for other HIV-infected men, and 2 for HIV-uninfected men, corresponding to demographically adjusted rate ratios (RRs) of 80.3 (95% confidence interval [CI], 42.7—151.1) for HIV-infected MSM and 26.7 (95% CI, 11.5—61.7) for other HIV-infected men compared with HIV-uninfected men. HIV-infected women had an anal cancer rate of 30/100 000 person-years, and no cases were observed for HIV-uninfected women. In a multivariable Poisson regression model, among HIV-infected individuals, the risk was higher for MSM compared with other men (RR, 3.3; 95% CI, 1.8—6.0), but no difference was observed comparing women with other men (RR, 1.0; 95% CI, 0.5—2.2). In comparison with the period 2000—2003, HIV-infected individuals had an adjusted RR of 0.5 (95% CI, .3—.9) in 1996—1999 and 0.9 (95% CI, .6—1.2) in 2004—2007. Conclusions. Anal cancer rates were substantially higher for HIV-infected MSM, other men, and women compared with HIV-uninfected individuals, suggesting a need for universal prevention efforts. Rates increased after the early antiretroviral therapy era and then plateaued.